GNE is a gene your body uses to make sialic acid, a sugar that helps protect and support many proteins on cell surfaces, especially in muscle. This gene helps your body keep muscles working smoothly over time. Pathogenic variants in the GNE gene can reduce sialic acid production and cause GNE myopathy, a rare inherited condition with slowly worsening muscle weakness. Symptoms often begin in the lower legs and usually start in early to mid adulthood.
What is a gene?
Genes are stretches of DNA that hold instructions cells use to make molecules or direct processes in the body. Certain genes carry the information needed to produce proteins, the parts of cells that do much of the work. Others mainly regulate when specific processes occur, where they occur, and how strongly they operate. Taken together, genes affect how the body develops and functions, and they can influence how you respond to food, stress, or medications. You can find more on this topic in the LearnHub.
Overview
GNEGene function
What if the gene works
The GNE gene helps your body make sialic acid, a sugar placed on many cell surface proteins. This supports normal cell communication and is especially important in muscle tissue.
Risk
What if the gene does not work
Variants in the GNE gene most often cause GNE myopathy, with gradually progressive muscle weakness that can range from milder to more limiting. Certain specific variants can instead cause sialuria, a metabolic condition with excess sialic acid.
Treatment
What does that mean for your treatment
No GNE-specific treatment or drug selection is currently established in clinical guidelines for people with pathogenic loss-of-function variants in the GNE gene. Treatments that aim to raise sialic acid levels, including N-acetyl-D-mannosamine, are under study for GNE myopathy, but they are not standard care yet.
Conditions associated with GNE
Gene function
What if the gene works
Your cells need a steady supply of sialic acid, a small sugar that sits on the surface of many proteins and fats. The GNE gene helps make sialic acid in the body. When this gene is working normally, cells can finish and maintain many surface molecules in a balanced way.
The GNE gene carries out the first two steps your cells use to make sialic acid. This small sugar is attached to many proteins and fats on the cell surface.
Sialic acid often forms the outer tip of sugar chains on cell molecules. That outer tip helps many proteins stay stable and work as expected at the cell surface.
By supporting these surface sugar caps, the GNE gene helps cells recognize signals and interact with nearby cells. This supports steady communication between cells and their environment.
What is a variant?
A genetic variant is a minor change in the DNA sequence within a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. At times, though, a variant can change gene function more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the GNE gene can change the shape or stability of its two-part enzyme, lowering how well cells make sialic acid, a sugar that helps protect many proteins. Some variants are milder and leave partial enzyme activity, while more disruptive variants reduce it further. This range helps explain how GNE gene variants affect muscle cells. In GNE myopathy, lower remaining activity may be linked to earlier onset or more marked weakness.
How variants are linked to conditions
Pathogenic variants in the GNE gene most often cause GNE myopathy, an inherited muscle condition that usually starts in adolescence or adulthood with foot drop or weakness in the lower legs. Inheriting two disease-causing variants in the GNE gene can confirm this diagnosis. Rarely, certain GNE gene variants cause sialuria, a separate inherited condition.
A variant is not necessarily a diagnosis
Across the general population, genetic variants are common and are a normal part of human biology. Most do not directly affect health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a confirmed diagnosis, especially when several genes and environmental factors play a role. In some situations, however, a single well-characterized variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For GNE, risk is mainly shaped by inheritance: people usually develop GNE-related muscle disease only if they inherit harmful changes in both copies of the GNE gene, while one changed copy usually means carrier status. Beyond that, there is not yet broadly confirmed evidence that specific lifestyle or environmental factors clearly increase or reduce risk.
Inheritance of GNE variants
The inheritance pattern for GNE-related conditions depends on the specific condition and variant type. Most often, GNE gene variants linked to GNE myopathy are inherited in an autosomal recessive pattern, which means a person inherits one altered copy from each parent; parents are usually healthy carriers, and each child has a 25% chance of inheriting both altered copies. In contrast, a rare condition linked to the GNE gene called sialuria follows an autosomal dominant pattern, so one altered copy can be enough to cause the condition and it can be passed from either parent to a child. This is why how GNE gene variants are inherited is not described by a single pattern for every GNE-related condition.
What does my GNE result mean for my family?
For many living with a GNE-related muscle condition, family members are most often affected in a recessive pattern, which means siblings may also have the condition or be carriers even if parents are healthy. Close relatives may want to learn whether they also carry the family’s GNE change. GNE can also be linked to a rarer condition that follows a dominant pattern, so what it means for relatives depends on the specific GNE result and condition involved.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for GNE variants usually uses a blood, saliva, or cheek swab sample. A lab reads the GNE gene to look for variants, and some tests also check for missing or extra pieces of DNA. Results may help confirm GNE myopathy or show carrier status.
When should I consider getting a genetic test?
Consider GNE testing if there is a personal or family history of a rare inherited muscle condition with slowly worsening weakness, often starting in the lower legs in early to mid-adulthood. It can also help clarify the cause of unexplained foot drop or muscle weakness when this pattern suggests GNE-related myopathy.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but the amount it explains varies with the condition and the specific type of variant. Over time, how the body functions is shaped by many factors, including lifestyle, environment, age, and medical history. In some conditions, particularly those affected by many genes, genetic information offers context rather than certainty and makes the most sense when considered with other parts of care. In other situations, a genetic result can give a clear answer. In areas like medication response, genetic results can also help put individual experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This helps explain why the same treatment works well for one person, has less effect in another, or causes more side effects in someone else. Small differences in genes can change how the body breaks down a drug, moves it through the body, or responds to it at its target. These differences are common and can influence how effective a medicine feels or how sensitive a person is to it.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can affect a person’s response to medications. It studies gene and drug patterns to help explain why the same treatment may work differently from one person to another. For many medicines, genes influence both how strongly a drug works and how the body handles it. This information can support more informed, more individualized treatment decisions. To explore this subject in greater detail, you can learn more in the LearnHub.
Drugs influenced by the GNE gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting how medicines will work, so questions about side effects, new symptoms, or changes in treatment are best discussed with your doctor.
History
Doctors first described the muscle condition now linked to the GNE gene in the 1980s, when separate groups reported what were then called Nonaka myopathy in Japan and hereditary inclusion body myopathy in families of Persian Jewish ancestry. At the time, these appeared to be different illnesses because the pattern of weakness and the family backgrounds were not the same. Scientific classifications changed as researchers learned more about the gene. In the early 2000s, studies showed that both conditions were caused by variants in the GNE gene, bringing them under one genetic explanation. This was an important step for diagnosis, research, and family counseling. Over time, the condition became more widely known as GNE myopathy.